Plain-English translation of NCT04891068 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called to see if it can boost your body's immune response against high-risk early-stage breast cancer. You would receive this medication as injections for five days before your planned surgery. Researchers want to understand whether this treatment helps immune cells in the tumor fight the cancer more effectively.
High-risk early-stage breast cancers can be aggressive and more likely to return, even after surgery. This medication is designed to wake up the immune system to attack cancer cells more powerfully, and this trial will measure whether it actually works before you have surgery.
You likely qualify if…
You likely don't qualify if…
You would attend a screening visit within 30 days to confirm you're eligible — this includes blood tests, physical exam, and review of your mammogram and tumor. Then you would come in on one day to receive the medication as injections under your skin for five consecutive days before your planned breast cancer surgery. The study team will monitor you closely with blood work and check-ins to ensure you tolerate the treatment well.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States